ACE and heart failure: Pathogenetic heart failure medical treatment was prescribed as follows: Angiotensin-converting enzyme (ACE) inhibitors or angiotensin II receptor blockers (ARB) were received by 69.7%, beta-adrenoceptor blockers by 81.9%, and mineralocorticoid antagonists by 66.7% of patients.